Publications by authors named "Martin Zenni"

Claim this Profile
C
Clopidogrel-Mediated P2Y Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Martin M Zenni

JACC Basic Transl Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2Y Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study.
Luis Ortega-Paz, Wilbert Bor, Francesco Franchi, Wout W A van den Broek, Fabiana Rollini, Martin M Zenni

JACC Cardiovasc Interv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Martin M Zenni

Thromb Haemost· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study.
Francesco Franchi, Fabiana Rollini, Luis Ortega-Paz, Latonya Been, Salvatore Giordano, Martin M Zenni

JACC Cardiovasc Interv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.
Francesco Franchi, Luis Ortega-Paz, Fabiana Rollini, Latonya Been, Andrea Rivas, Martin Zenni

EuroIntervention· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.
Francesco Franchi, Luis Ortega-Paz, Fabiana Rollini, Mattia Galli, Latonya Been, Martin M Zenni

JACC Cardiovasc Interv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease.
Mattia Galli, Fabiana Rollini, Latonya Been, Martin M Zenni, Dominick J Angiolillo

J Thromb Thrombolysis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy.
Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Martin M Zenni

Eur Heart J Cardiovasc Pharmacother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease.
Francesco Franchi, Fabiana Rollini, Latonya Been, Naji Maaliki, Patrick Abou Jaoude, Martin M Zenni

Eur Heart J Cardiovasc Pharmacother· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease.
Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Martin M Zenni

Thromb Haemost· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swinging heart seen on single-photon emission computed tomography (SPECT).
Shreya Mishra, Dominika Zoltowska, Martin Zenni, Srinivasan Sattiraju

BMJ Case Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor.
Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Martin M Zenni

JACC Cardiovasc Interv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study.
Francesco Franchi, Fabiana Rollini, Latonya Been, Maryuri Briceno, Naji Maaliki, Martin M Zenni

Circulation· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing.
Francesco Franchi, Fabiana Rollini, Jose Rivas, Andrea Rivas, Malhar Agarwal, Martin M Zenni

JACC Basic Transl Sci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.
Francesco Franchi, Fabiana Rollini, Gabriel Faz, Jose Ramon Rivas, Andrea Rivas, Martin M Zenni

J Am Heart Assoc· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
Francesco Franchi, Fabiana Rollini, Emilio Garcia, Jose Rivas Rios, Andrea Rivas, Martin M Zenni

Thromb Haemost· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study.
Francesco Franchi, Fabiana Rollini, Victor Kairouz, Jose Rivas Rios, Andrea Rivas, Martin M Zenni

JACC Basic Transl Sci· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.
Francesco Franchi, Fabiana Rollini, Yongwhi Park, Jenny Hu, Megha Kureti, Martin M Zenni

JACC Cardiovasc Interv· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Francesco Franchi, Fabiana Rollini, Andrea Rivas, Mustafa Wali, Maryuri Briceno, Martin M Zenni

Circulation· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study.
Francesco Franchi, Fabiana Rollini, Jose Rivas Rios, Andrea Rivas, Malhar Agarwal, Martin M Zenni

Circulation· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case series.
Ignacio M Seropian, Dominick J Angiolillo, Martin M Zenni, Theodore A Bass, Luis A Guzman

Catheter Cardiovasc Interv· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chronic kidney disease on platelet P2Y receptor signalling in patients with type 2 diabetes mellitus.
Lydia R Engwenyu, Francesco Franchi, Fabiana Rollini, Jung Rae Cho, Christopher DeGroat, Martin Zenni

Thromb Haemost· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y receptor inhibitors.
Fabiana Rollini, Francesco Franchi, Kamaldeep Singh, Jung Rae Cho, Mona Bhatti, Martin Zenni

Thromb Haemost· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
Francesco Franchi, Fabiana Rollini, Niti Aggarwal, Jenny Hu, Megha Kureti, Martin M Zenni

Circulation· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.
Francesco Franchi, Gabriel Todd Faz, Fabiana Rollini, Yongwhi Park, Jung Rae Cho, Martin M Zenni

JACC Cardiovasc Interv· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis